PTC Therapeutics, Inc.
PTCT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $1.73B | $807M | +115% |
| Operating income | $867M | −$303M | |
| Net income | $683M | −$363M |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 29, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $358M | $211M | +69.6% |
| Operating income | $25.1M | $3.00M | +737% |
| Net income | −$51.7M | $15.9M |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was PTC Therapeutics's revenue in FY2025?
- $1.73B in FY2025 (Fiscal year ended Dec 31, 2025), +115% vs $807M a year earlier, per its 10-K filed Feb 2026.
- Was PTC Therapeutics profitable in FY2025?
- Yes: net income was $683M and operating income $867M in FY2025.
- What was PTC Therapeutics's revenue in Q3 2026?
- $358M (+69.6% vs a year earlier), per its Form 10-Q filed Oct 29, 2026.